Julia Mueller

The UK Congress on Obesity, hosted by @ukaso.bsky.social, focused on "Understanding Obesity: From Research to Clinical and Public Health Practice." Researchers from @mrcepid.bsky.social attended to enhance our knowledge of obesity.

Excited to present our new large national randomised controlled trial on a digital, scalable weight loss maintenance intervention led by @amyahern.bsky.social at #UKCO2025. We're currently recruiting from various commissioned weight loss interventions throughout the UK. @ukaso.bsky.social

‘I lost so much weight, my husband thought I was terminally ill’: why do people lie about taking Ozempic? The dramatic results of weight-loss drugs often come with a side order of stigma, as though it’s ‘cheating’ not to stick to willpower, diet and exercise alone. Is that why so many are telling no one –...

Stigma and social pressure continue to shape how GLP-1 medications (like Ozempic) are discussed and experienced.

ASO’s Dr @julia-mueller-phd.bsky.social contributes to this Guardian piece exploring the complex narratives around obesity treatment.

tinyurl.com/vrabuzfy

📢ASO members - nominate a leader in obesity research!

Nominations are open for the 2025 ASO Honorary Fellowship, awarded at UKCO Aberdeen (10–11 Sept).

• Nominees don’t need to be ASO members

📅Deadline: 1 June (midnight)

Submit here 👉🏼 shorturl.at/291jl

‘I lost so much weight, my husband thought I was terminally ill’: why do people lie about taking Ozempic? The dramatic results of weight-loss drugs often come with a side order of stigma, as though it’s ‘cheating’ not to stick to willpower, diet and exercise alone. Is that why so many are telling no one –...

This is a great read; I commend the @theguardian.com for this thoughtful and sensitive piece on new weight loss medications, and why some people choose to keep taking them a secret. Really pleased that I was able to contribute my expertise to this work. www.theguardian.com/lifeandstyle...

Are you an early career researcher in obesity or know someone who is?

Join us on 18 June for an afternoon of research talks, fellowship advice, and networking.

📍 Hybrid | University of Leeds & online
🕐 1–4.30pm

Extremely excited to see this important and rigorously conducted piece of work published! Well done @laurakudlek.bsky.social

We're hiring intervention facilitators for our national trial of an acceptance-based weight maintenance intervention. Perfect for health coaches/assistant psychs/student dietitians with an interest in weight management. www.jobs.cam.ac.uk/job/51082/

📢 Applications now open for the #UKCO2025 Early Career Researcher Event!

🧠 Career talks
🛠️ Transferable skills workshops
🤝 Network with fellow ECRs in obesity research
🎤 5 brilliant speakers
Spaces are limited—apply by 19 May!

🔗 Learn more & apply: shorturl.at/XoYfe

Thanks @ukaso.bsky.social for sharing our new findings from the GLoW trial! This will likely be of interest to many ASO members. Happy to provide further information and answer any questions in the comments or via direct message. 💬🗨️💡🙂

Looking forward to this annual Early Career event which will take place ahead of the UK Congress on Obesity! 📢Calling all early career researchers interested in obesity to mark the date in your calendars 🗓️✍️ Further details to follow soon! Applications will open in early April and close mid May.

...Daniel Pollard, Jenny Woolston, Emma Lachassseigne, Marie Stubbings, Fiona Whittle, Rebecca A. Jones, Clare E. Boothby, Robbie Duschinsky, Jennifer Bostock, Nazrul Islam, Simon Griffin

👏Huge thanks to all co-investigators and supporters, especially Chief Investigator @amyahern.bsky.social, co-first author Penny Breeze, and all co-authors: Francesco Fusco, Stephen Sharp, Katharine Pidd, @alan-brennan.bsky.social, Andrew Hill, Stephen Morris, Carly A. Hughes, Sarah E. Bates...

... and this may address an important gap in services for those who could benefit from weight loss but for whom more intensive interventions are unsuitable or unavailable.

TAKE HOME: Commercial behavioural weight management plus tailored diabetes education may lead to additional weight loss compared to current standard care and is likely to be cost-effective in patients with newly diagnosed type 2 diabetes...

💰💵The intervention was more expensive than standard care, but when we projected the long-term impact on health and healthcare costs, the results suggested that investing in this type of intervention could offer better value for money over a lifetime.

Findings: The intervention did not improve average blood glucose (HbA1c) compared to standard care diabetes education, but it did help people lose more weight and achieve diabetes remission.

Participants (577 adults living with overweight or obesity and recently diagnosed with type 2 diabetes) were assigned to either the new intervention combining personalised diabetes education with commercial weight management (Weight Watchers) or to a standard care diabetes education workshop

The aim of our study was to find out if a new intervention combining diabetes education with commercial behavioural weight management would help people with a recent diagnosis of type 2 diabetes to lower their average blood sugar and lose weight compared to current standard care.

There is strong evidence that commercially available behavioural weight management programmes are cost-effective and have sustained impacts on weight for people with overweight or obesity, but evidence for these programmes in type 2 diabetes is limited.

📢We are pleased to announce the publication of our Glucose Lowering through Weight Management (GLoW) trial in @diabetologiajnl.bsky.social, led by @amyahern.bsky.social and other researchers from @mrcepid.bsky.social, @sheffielduni.bsky.social & @universityofleeds.bsky.social🔗http://bit.ly/3Qaf51w 🧵

#HiSciSky! Great to see so many new faces here. If you would like to follow more health psychology researchers like me, take a look at these two starter packs:
#1 go.bsky.app/9Xfk7Wo
#2 go.bsky.app/zEDDL2
Please let me know if you would like to be added!